STONEPINE CAPITAL MANAGEMENT, LLC enters QUOIN PHARMACEUTICALS, LTD. with 3.27M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Indirect Derivatives

STONEPINE CAPITAL MANAGEMENT, LLC

Filed: 2/2/2026ACC: 0000935836-26-000064

InsiderSTONEPINE CAPITAL MANAGEMENT, LLCCIK 1440771

→

IssuerQUOIN PHARMACEUTICALS, LTD.CIK 1671502

10% Owner

Since Jan 2026

3.27M

Baseline shares

0.00

Direct ownership

0 positions

566.06K

Derivative underlying

5 instruments

Security positions

3.27M indirect

Non-Derivative Holdings1

Ordinary Shares

Indirect

Shares owned3.27M

Total

3.27M indirect3.27M

Security Title	Shares Owned	Ownership Type
Ordinary Shares	3.27M	Indirect
Total	3.27M	3.27M indirect

Derivative Holdings5

Series K Warrants

Indirect

Underlying security

ADS

Underlying shares

121.21K

Shares owned

N/A

Exercise price

12.375

Expiration

—

Exercise window

—

Series J Warrants

Indirect

Underlying security

ADS

Underlying shares

121.21K

Shares owned

N/A

Exercise price

12.375

Expiration

—

Exercise window

—

Series H Warrants

Indirect

Underlying security

ADS

Underlying shares

121.21K

Shares owned

N/A

Exercise price

9.075

Expiration

—

Exercise window

—

Series I Warrants

Indirect

Underlying security

ADS

Underlying shares

121.21K

Shares owned

N/A

Exercise price

10.3125

Expiration

—

Exercise window

—

Pre-Funded Warrants

Indirect

Underlying security

ADS

Underlying shares

81.21K

Shares owned

N/A

Exercise price

0.0001

Expiration

—

Exercise window

—

Total

Underlying

566.06K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Series K Warrants Indirect	ADS	12.375	—	—	121.21K	N/A
Series J Warrants Indirect	ADS	12.375	—	—	121.21K	N/A
Series H Warrants Indirect	ADS	9.075	—	—	121.21K	N/A
Series I Warrants Indirect	ADS	10.3125	—	—	121.21K	N/A
Pre-Funded Warrants Indirect	ADS	0.0001	—	—	81.21K	N/A
Total					566.06K	0.00